Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to achieve a significant increase in net profit for the first half of 2025, with a forecasted growth of 98% to 119% year-on-year, driven by the fulfillment of existing orders [3] - The merger with China Shipbuilding Industry Corporation is progressing, which is anticipated to enhance operational efficiency and profitability [4] - The long-term outlook for the shipbuilding industry remains positive, supported by ongoing demand for new vessels and environmental upgrades [4] Summary by Sections Earnings Forecast and Valuation - Total revenue is projected to grow from 748.39 billion RMB in 2023 to 1,141.67 billion RMB by 2027, with a compound annual growth rate (CAGR) of approximately 12.57% [1] - Net profit attributable to shareholders is expected to rise from 295.7 billion RMB in 2023 to 124.14 billion RMB in 2027, reflecting a substantial increase in profitability [1] - The earnings per share (EPS) is forecasted to increase from 0.66 RMB in 2023 to 2.78 RMB in 2027, indicating strong growth potential [1] Performance Highlights - As of May 2025, the company holds 322 vessels in its order book, equating to 24.61 million deadweight tons, with production capacity scheduled until 2029 [3] - The company’s performance is expected to exceed market expectations due to the release of previously suppressed demand and the synergistic effects of the merger [3][4] Market Position and Industry Outlook - The company is projected to capture approximately 15% of the global order book and over 14% of global shipbuilding completion volume post-merger [4] - The shipbuilding industry is expected to continue its upward cycle, supported by stringent environmental regulations and the aging of existing vessels [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has announced a performance forecast for the first half of 2025, expecting revenue of 10.63 to 10.84 billion yuan, representing a year-on-year growth of 35.0% to 37.7%. The net profit attributable to the parent company is expected to be between 2.31 to 2.45 billion yuan, a year-on-year increase of 33.5% to 41.6% [8] - The company continues to focus on driving sales and expanding its national strategy, with an expected increase in the number of distribution points to over 4 million [8] - The company is actively exploring multi-category development, with new products like fruit juice tea contributing to sales growth [8] - Despite a slight decline in net profit margin due to increased marketing expenses and a high base from the previous year, the long-term growth momentum remains intact [8] Financial Summary - Total revenue forecast for 2023 is 11.263 billion yuan, with a year-on-year growth of 32.42%. The net profit attributable to the parent company is projected at 2.04 billion yuan, a year-on-year increase of 41.60% [1] - For 2024, total revenue is expected to reach 15.839 billion yuan, with a growth rate of 40.63%, and net profit is forecasted at 3.327 billion yuan, reflecting a 63.09% increase [1] - The company anticipates a total revenue of 20.856 billion yuan in 2025, with a year-on-year growth of 31.67%, and net profit of 4.654 billion yuan, a 39.90% increase [1] - The projected earnings per share (EPS) for 2025 is 8.95 yuan, with a price-to-earnings (P/E) ratio of 32.39 based on the current price [1]

1. Report Industry Investment Rating No relevant information provided. 2. Core Viewpoints The report presents a weekly update on the large refining and chemical industry, covering various aspects such as price trends, profit margins, inventory levels, and开工 rates in different sectors including polyester, refining, and chemicals. It also provides data on the stock performance and earnings forecasts of major private refining and chemical companies [2][8][9]. 3. Summary by Directory 3.1 Big Refining Weekly Data Briefing - **Stock Performance and Earnings Forecast**: The report tracks the price changes of 6 major private refining companies over different time - frames (weekly, monthly, quarterly, yearly, and year - to - date in 2025). It also provides earnings forecasts for these companies from 2024 to 2027, including total market capitalization, net profit attributable to shareholders, PE, and PB [8]. - **Oil Prices and Refining Spreads**: International crude oil prices (Brent and WTI) decreased this week. The domestic refining project spread remained stable with a 0.0% week - on - week change, while the foreign refining project spread decreased by 9.4% week - on - week [8]. - **Polyester Sector**: - **Raw Materials and Intermediate Products**: PX average price decreased by $17.0/ton week - on - week, and its spread over crude oil decreased by $29.4/ton. MEG price increased by 14.3 yuan/ton, and PTA price decreased by 185.0 yuan/ton. - **Polyester Filament**: POY, FDY, and DTY prices decreased, and their profit margins also declined. Inventory levels of POY, FDY, and DTY increased, while the开工 rate of polyester filament increased to 91.9%. The downstream weaving开工 rate decreased to 56.2%, and the raw material inventory of weaving enterprises decreased, while the finished product inventory increased [2][9]. - **Other Polyester Products**: The price of polyester staple fiber decreased, but its profit margin increased. The price of polyester bottle - grade chips decreased, and its profit margin also decreased [9]. - **Refining Sector**: - **Domestic Refined Oil**: The prices of gasoline, diesel, and aviation kerosene in China decreased this week. - **US Refined Oil**: The prices of gasoline, diesel, and aviation kerosene in the US increased this week. - **European and Singaporean Refined Oil**: The prices of refined oil products in Europe and Singapore showed different trends, with some increasing and some decreasing [9]. - **Chemical Sector**: The prices and spreads of various chemical products such as pure benzene, styrene, acrylonitrile, and polyethylene decreased to varying degrees [9]. 3.2 Big Refining Weekly Report - **2.1 Big Refining Index and Project Spread Trends**: The report may contain data on the performance of the big refining index and the spread trends of domestic and foreign refining projects, but specific data is not fully presented in the provided text [11][12]. - **2.2 Polyester Sector**: It includes multiple data series related to the polyester sector, such as the relationship between crude oil, PX, PTA, and polyester filament prices, profit margins,开工 rates, inventory levels, and production and sales rates [22][23][37]. - **2.3 Refining Sector**: It provides detailed data on the relationship between crude oil and refined oil prices (gasoline, diesel, and aviation kerosene) in different regions (China, the US, Europe, and Singapore), including price spreads and changes [79][89][94]. - **2.4 Chemical Sector**: It presents data on the relationship between crude oil and various chemical product prices (such as polyethylene, polypropylene, EVA, etc.), including price spreads and changes [129][130][134].

Investment Rating - The report maintains an "Accumulate" rating for the non-bank financial industry [1] Core Views - The non-bank financial sector has shown strong performance recently, with all sub-sectors outperforming the CSI 300 index in the last five trading days [9] - The report highlights the significant increase in trading volume in the securities sector, with a year-on-year increase of 120% in daily average stock trading volume as of July 11, 2025 [15] - The insurance sector is expected to benefit from long-term capital advantages due to new assessment criteria for state-owned insurance companies [23] - The multi-financial sector is entering a stable transition period, with trust assets continuing to grow but profits declining significantly [31] Summary by Sections 1. Recent Performance of Non-Bank Financial Sub-Sectors - In the last five trading days (July 7-11, 2025), the multi-financial sector rose by 11.89%, the securities sector by 4.58%, and the insurance sector by 1.72%, while the overall non-bank financial sector increased by 3.94% compared to a 0.82% rise in the CSI 300 index [9][11] 2. Non-Bank Financial Sub-Sector Insights 2.1 Securities - Trading volume has significantly increased, with a daily average stock trading amount of CNY 16,688 billion, up 120% year-on-year as of July 11, 2025 [15] - The China Securities Association has implemented measures to strengthen self-regulation and promote high-quality development in the securities industry [19] 2.2 Insurance - New long-term assessment criteria for state-owned insurance companies have been introduced, focusing on net asset return and capital preservation over a five-year period [23] - The insurance sector's valuation is currently at 0.62-0.95 times the 2025E P/EV, which is considered historically low, maintaining an "Accumulate" rating [28] 2.3 Multi-Financial - The trust industry saw its asset scale reach CNY 29.56 trillion in 2024, a year-on-year growth of 23.58%, but profits dropped significantly by 45.5% [31] - The futures market experienced a trading volume of 740 million contracts in June 2025, with a transaction value of CNY 52.79 trillion, reflecting year-on-year growth of 28.91% and 17.40%, respectively [34] 3. Industry Ranking and Key Company Recommendations - The report ranks the insurance sector highest, followed by securities and other multi-financial sectors, recommending companies such as China Ping An, New China Life, China Pacific Insurance, CITIC Securities, and Tonghuashun [44]

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints The report focuses on the weekly data of the basic chemical industry, showing that the demand is weak and the MDI price is running weakly. It details the price and profit changes of various chemical products in different sectors such as polyurethane, oil - gas - olefin, and coal - chemical industries, and also tracks the stock price, market value, and profit of related listed companies [1][2]. 3. Summary by Directory 3.1 Basic Chemical Weekly Data Briefing - **Related Company Performance Tracking** - **Stock Price Fluctuations**: From July 11, 2025, the basic chemical index rose 1.5% in the past week, 2.5% in the past month, 11.1% in the past three months, 20.9% in the past year, and 8.9% since the beginning of 2025. Among related companies, Wanhua Chemical rose 3.0% in the past week, Baofeng Energy fell 2.6%, Satellite Chemical fell 1.8%, and Hualu Hengsheng fell 1.5% [8]. - **Profit Tracking**: As of July 11, 2025, Wanhua Chemical had a total market value of 174.9 billion yuan, with a net profit attributable to the parent company of 13.033 billion yuan in 2024A, 13.966 billion yuan in 2025E, 16.864 billion yuan in 2026E, and 19.233 billion yuan in 2027E. Similar data is provided for Baofeng Energy, Satellite Chemical, and Hualu Hengsheng [8]. - **Polyurethane Industry Chain** - **Product Prices and Profits**: This week, the average prices of pure MDI, polymer MDI, and TDI were 16,640 yuan/ton, 14,800 yuan/ton, and 12,120 yuan/ton respectively, with week - on - week changes of - 300 yuan/ton, - 420 yuan/ton, and + 120 yuan/ton. The corresponding gross profits were 3,565 yuan/ton, 2,765 yuan/ton, and 1,110 yuan/ton, with week - on - week changes of - 153 yuan/ton, - 295 yuan/ton, and + 213 yuan/ton [2][8]. - **Oil - Gas - Olefin Industry Chain** - **Raw Material Prices**: The average prices of ethane, propane,动力煤, and naphtha this week were 1,254 yuan/ton, 4,135 yuan/ton, 483 yuan/ton, and 4,211 yuan/ton respectively, with week - on - week increases of 56 yuan/ton, 65 yuan/ton, 13 yuan/ton, and 102 yuan/ton [2]. - **Product Prices and Profits**: The average price of polyethylene was 7,931 yuan/ton, down 15 yuan/ton week - on - week. The theoretical profits of ethane cracking, CTO, and naphtha cracking to produce polyethylene were 1,304 yuan/ton, 2,046 yuan/ton, and 68 yuan/ton respectively, with week - on - week decreases of 62 yuan/ton, 44 yuan/ton, and 119 yuan/ton. The average price of polypropylene was 7,064 yuan/ton, down 56 yuan/ton week - on - week. The theoretical profits of PDH, CTO, and naphtha cracking to produce polypropylene were - 45 yuan/ton, 1,670 yuan/ton, and - 127 yuan/ton respectively, with week - on - week decreases of 101 yuan/ton, 71 yuan/ton, and 145 yuan/ton [2]. - **Coal - Chemical Industry Chain** - **Product Prices and Profits**: The average prices of synthetic ammonia, urea, DMF, and acetic acid this week were 2,228 yuan/ton, 1,808 yuan/ton, 4,255 yuan/ton, and 2,301 yuan/ton respectively, with week - on - week changes of - 13 yuan/ton, + 11 yuan/ton, + 235 yuan/ton, and - 49 yuan/ton. The corresponding gross profits were 343 yuan/ton, 148 yuan/ton, 141 yuan/ton, and 12 yuan/ton, with week - on - week changes of - 9 yuan/ton, + 3 yuan/ton, + 327 yuan/ton, and + 7 yuan/ton [2]. 3.2 Basic Chemical Weekly Report - **Basic Chemical Index Trend**: No specific content provided other than the mention of the index and related data in the data briefing section [12]. - **Polyurethane Sector**: Analyzes the price trends of pure benzene, pure MDI, polymer MDI, and TDI, as well as the price and profit of polymer MDI, TDI, and pure MDI [17][18]. - **Oil - Gas - Olefin Sector**: Covers the price trends of MB ethane, NYMEX natural gas, East China propane, Brent crude oil, domestic动力煤, and naphtha, and the profit of different production processes such as ethane cracking, naphtha cracking, MTO, and CTO for producing PE and PP [24][30]. - **Coal - Chemical Sector**: Analyzes the price trends and profits of coal - coking products, traditional coal - chemical products, and new materials such as coking coal, coke, synthetic ammonia, methanol, urea, DMF, acetic acid, DMC, oxalic acid, octanol, adipic acid, caprolactam, and PA6 [10][42].

Market Overview - The average daily trading volume of the entire A-share market reached approximately 1.50 trillion CNY, a slight increase of nearly 55 billion CNY compared to the previous week[8] - The Shanghai Composite Index showed a weekly increase of 1.09%[12] Market Style Performance - Small-cap stocks outperformed large-cap stocks, with small-cap value index rising by 2.71% and small-cap growth index increasing by 2.31%[12] - The relative advantage of growth stocks over value stocks remained in positive territory, indicating a favorable trend for growth investments[17] Participant Performance - The market sentiment index rose by 3.56%, indicating strong performance from active funds[20] - The private equity heavy index showed a weekly increase of 1.89%, outperforming other indices[20] Market Sentiment - The total margin trading balance increased to over 1.87 trillion CNY, reflecting a stable market sentiment[28] - The number of stocks hitting the daily limit up was 78, while those hitting the limit down was 7, indicating a generally positive market atmosphere[23] Sector Trends - Strong sectors included rare earths, with companies like Northern Rare Earth announcing price increases, and the CRO sector, driven by performance boosts from companies like WuXi AppTec[41] - The brokerage sector also showed strength, benefiting from the overall market rally[41] Future Outlook - Upcoming events include the 9th Rockchip Developer Conference on July 17-18, which may impact TMT sectors[42] - The focus for mid-term industry allocation will be on active domestic circulation, technological self-reliance, and expanding openness[46]

Investment Rating - The report maintains an "Overweight" rating for the engineering machinery and shipbuilding sectors, emphasizing the importance of new technology iterations in lithium battery equipment opportunities [1]. Core Insights - The engineering machinery sector shows resilience in domestic sales and continued high demand for exports, with excavator sales in June 2025 reaching 18,804 units, a year-on-year increase of 13% [2]. - The shipbuilding industry is experiencing a recovery in sentiment, with a significant increase in the order backlog, and Chinese shipbuilding companies are expected to see substantial profit growth in the first half of 2025 [3]. - The solid-state battery equipment sector is in a trial production phase, with equipment manufacturers actively validating and iterating technologies, anticipating a large-scale verification period in the second half of 2025 [3][20]. - The railway transportation sector is benefiting from steady growth in fixed asset investment, with China Railway's profits expected to increase significantly in the first half of 2025 [4]. Summary by Sections Engineering Machinery - Domestic excavator sales in June 2025 reached 8,136 units, a 6% year-on-year increase, while exports totaled 10,668 units, up 19% [2]. - The sector is expected to maintain considerable growth due to government funding and increasing demand from emerging markets [2]. Shipbuilding Industry - The new ship price index remains high, with a 20% year-on-year increase in the order backlog [3]. - Chinese shipbuilding companies are projected to achieve net profits of 2.8 to 3.1 billion yuan in the first half of 2025, marking a year-on-year growth of 98% to 119% [3]. Solid-State Battery Equipment - The solid-state battery sector is expected to enter a large-scale verification phase in late 2025, with significant demand for new equipment arising from the transition to dry processing methods [20][21]. - Key players in the solid-state battery equipment market include leading suppliers like Xian Dao Intelligent and Hangke Technology [22]. Railway Transportation - As of May 2025, China's railway fixed asset investment reached 242.1 billion yuan, a 6% year-on-year increase [4]. - China Railway is expected to report a net profit of 6.72 to 7.56 billion yuan in the first half of 2025, reflecting a year-on-year growth of 60% to 80% [4].

Group 1 - The report highlights a steady increase in domestic electrification rates and a strong recovery in European sales, with global sales expected to grow by 21% in 2025 and maintain over 15% growth in 2026 [2][3] - In 2025, domestic electric vehicle sales are projected to reach 5.61 million units, a year-on-year increase of 44%, with an annual growth forecast of 25% [2][5] - The report anticipates a robust demand for lithium batteries, with a revised growth estimate of over 30% in 2025 and nearly 20% in 2026, driven by strong energy storage policies and market dynamics [2][3] Group 2 - The report indicates that the profitability of the industry has begun to recover slightly, with leading companies starting to expand production in an orderly manner, while smaller firms continue to exit the market [2][3] - The report notes a significant disparity in profitability across different segments of the supply chain, with leading battery manufacturers maintaining high profit levels compared to second-tier manufacturers [2][3] - The solid-state battery technology is highlighted as a key area of focus, with advancements expected in sulfide-based materials and core equipment, indicating a rapid acceleration in industrialization [2][3] Group 3 - Investment recommendations emphasize focusing on leading lithium battery companies and those accelerating the industrialization of solid-state technologies, with specific companies identified for potential investment [2][3] - The report suggests that the lithium carbonate price has reached a bottom, making it favorable to invest in companies with quality resources [2][3] - The report identifies several companies in the solid-state battery sector that are expected to benefit from technological advancements and market demand [2][3]

证券研究报告·固定收益·固收点评 固收点评 20250712 二级资本债周度数据跟踪 （20250707-20250711） [Table_Tag] [Table_Summary] 观点 ◼ 一级市场发行与存量情况： 本周（20250707-20250711）银行间市场及交易所市场共新发行二级资本 债 2 只，发行规模为 530.00 亿元。发行年限为 10Y；发行人性质为央企 子公司、中央金融企业；主体评级为 AAA；发行人地域为广东省、北京 市。 截至 2025 年 7 月 11 日，二级资本债存量余额达 46,531.35 亿元，较上 周末（20250620）增加 523.0 亿元。 ◼ 二级市场成交情况： 本周（20250707-20250711）二级资本债周成交量合计约 1855 亿元，较 上周减少 61 亿元，成交量前三个券分别为 25 中行二级资本债 01BC （130.29 亿元）、25 工行二级资本债 02BC（102.48 亿元）和 25 工行 二级资本债 01BC（86.30 亿元）。 分发行主体地域来看，成交量前三为北京市、上海市和广东省，分别约 为 1392 亿元、125 亿元和 7 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is positioned to capture a significant share of the rapidly growing GLP-1 drug market, with its innovative three-target strategy in collaboration with Novo Nordisk [9][38]. - The company has a robust pipeline with over 100 products under development, showcasing its commitment to innovation and market competitiveness [14][43]. - Financial projections indicate steady revenue growth, with expected revenues of 138.6 billion, 150.0 billion, and 162.6 billion yuan for 2025, 2026, and 2027 respectively, alongside a net profit forecast of 31.1 billion, 31.0 billion, and 33.8 billion yuan for the same years [9][11]. Summary by Sections 1. Company Overview - Founded in 1990 and listed in Hong Kong in 2007, the company has evolved into a large-scale pharmaceutical group with a diverse product range across APIs, formulations, biopharmaceuticals, and animal health [14]. - The company emphasizes technological innovation, with multiple R&D institutions and over 100 patents granted [14]. 2. Market Potential - The GLP-1 drug market is projected to reach a peak sales potential of approximately 680 billion yuan in China, driven by increasing obesity rates and a growing health consciousness among the population [33][37]. - The company’s UBT251, a three-target weight loss drug, has shown promising clinical results and is expected to outperform competitors [41][42]. 3. Financial Performance - The company’s total revenue has grown from 84.24 billion yuan in 2019 to an expected 137.59 billion yuan in 2024, with a CAGR of 10.31% [20][29]. - Net profit has increased significantly, with projections indicating a return to growth after a slight decline in 2024 due to temporary pressures [20][26]. 4. R&D and Pipeline - The company has a rich pipeline focusing on various therapeutic areas, including diabetes, weight management, and autoimmune diseases, with several products in advanced clinical stages [43][47]. - Recent FDA approval for UBT37034, a second-generation gastrointestinal hormone, enhances the company’s potential in the weight management sector [47]. 5. Competitive Landscape - The report highlights the competitive dynamics of the GLP-1 market, with major players like Novo Nordisk and Eli Lilly leading the charge, while the company aims to carve out its niche with innovative products [38][39].